chronic obstructive pulmonary disease copd prevalent preventable disease associated high morbidity mortality severe intermediate aat deficiency serum levels NUMBER micromoll1 respectively increase risk copd active smokers little known interaction severe intermediate aat deficiency modifiable copd risk factors active smoking study medline search carried studies investigating combined effect environmental inhalants occupation passive smoking aat deficiency lung total NUMBER studies using established methods assessment aat deficiency included review occupational exposures passive smoking affected lung function decline prevalence respiratory symptoms studies investigating subjects severe aat deficiency NUMBER studies focus intermediate aat deficiency study designs prohibited formal assessment effect modification interaction intermediate aat deficiency passive smoking identified studies children additional study limitations included small sample size poor adjustment confounding misclassification environmental exposure aat activity conclusion epidemiological studies associated biobanks needed identify interactions population subgroups susceptible deficiency alpha1 antitrypsin NUMBER NUMBER population based gene environment alpha1 antitrypsin